New MMA methodology for drug prices is a big change for many payers
As we move into 2005, injectable industry stakeholders-including payers, providers, manufacturers and regulators-are evaluating the impact of the Medicare Modernization Act (MMA) on their business practices.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
